<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font32 { font-size : 32; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font32">EBV </span>
   <span class="font22">virus </span>
   <span class="font22">antiviral </span>
   <span class="font20">[]. </span>
   <span class="font20">viral </span>
   <span class="font20">{border-style </span>
   <span class="font19">px;} </span>
   <span class="font18">#ffffff;} </span>
   <span class="font17">Epstein-Barr </span>
   <span class="font17">infection </span>
   <span class="font15">DNA </span>
   <span class="font15">prophylaxis </span>
   <span class="font15">treatment </span>
   <span class="font15">MBV </span>
   <span class="font15">replication </span>
   <span class="font14">activity </span>
   <span class="font14">drugs </span>
   <span class="font14">early </span>
   <span class="font14">px; </span>
   <span class="font14">{font-family </span>
   <span class="font13">However, </span>
   <span class="font13">PTLD </span>
   <span class="font13">active </span>
   <span class="font13">font-size </span>
   <span class="font13">infectious </span>
   <span class="font13">lymphoproliferative </span>
   <span class="font13">recipients </span>
   <span class="font13">Agents </span>
   <span class="font13">acute </span>
   <span class="font13">clinical </span>
   <span class="font13">double; </span>
   <span class="font13">effect </span>
   <span class="font13">effects </span>
   <span class="font13">human </span>
   <span class="font13">incidence </span>
   <span class="font13">inhibition </span>
   <span class="font13">late </span>
   <span class="font13">oral </span>
   <span class="font13">used </span>
   <span class="font12">Epsteinâ€“Barr </span>
   <span class="font12">[,]. </span>
   <span class="font12">acyclovir </span>
   <span class="font12">associated </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">cellular </span>
   <span class="font12">inhibitors </span>
   <span class="font12">inhibits </span>
   <span class="font12">latent </span>
   <span class="font12">load </span>
   <span class="font12">nucleoside </span>
   <span class="font12">primary </span>
   <span class="font12">received </span>
   <span class="font12">solid; </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font12">ACV </span>
   <span class="font12">Acyclovir </span>
   <span class="font12">EBV-positive </span>
   <span class="font12">GCV </span>
   <span class="font12">HCMV </span>
   <span class="font12">Maribavir </span>
   <span class="font12">VALM </span>
   <span class="font12">approved </span>
   <span class="font12">bold </span>
   <span class="font12">carcinoma </span>
   <span class="font12">cases </span>
   <span class="font12">cells </span>
   <span class="font12">courier; </span>
   <span class="font12">cytomegalovirus </span>
   <span class="font12">dependent </span>
   <span class="font12">disease </span>
   <span class="font12">effective </span>
   <span class="font12">em; </span>
   <span class="font12">ganciclovir </span>
   <span class="font12">group </span>
   <span class="font12">infected </span>
   <span class="font12">mononucleosis </span>
   <span class="font12">mutations </span>
   <span class="font12">nasopharyngeal </span>
   <span class="font12">onset </span>
   <span class="font12">placebo </span>
   <span class="font12">pt;} </span>
   <span class="font12">results </span>
   <span class="font12">significantly </span>
   <span class="font12">therapy </span>
   <span class="font12">versus </span>
  </p>
 </body>
</html>
